PSMA PET/CT在前列腺癌中的预后价值
PSMA在前列腺癌中广泛表达,其表达水平反映肿瘤侵袭性,并可作为诊疗一体化的靶点。PSMA PET成像在活检前、分期、生化复发定位及系统治疗反应预测中均具预后价值,人工智能应用于PSMA PET图像有望进一步提升预后判断能力。
要点
- 活检前前列腺病灶PSMA高摄取与组织学临床显著前列腺癌相关性好。
- 分期时PSMA PET优于常规影像,影像表现可预测治疗后结局。
- 生化复发时PSMA PET是最敏感的定位手段,病灶数目越多挽救治疗结局越差。
核心结论
- PSMA PET成像在前列腺癌多个临床场景中具有预后价值,人工智能应用于PSMA PET图像有望用于前列腺癌管理的预后判断。
研究设计与样本
- 综述,讨论PSMA PET/CT在前列腺癌中的预后价值。
主要发现
- 活检前前列腺病灶PSMA高摄取与组织学临床显著前列腺癌相关性好。
- 分期时PSMA PET在原发性前列腺癌准确分期方面优于常规影像,影像表现可预测治疗后结局。
- 生化复发时PSMA PET已成为定位复发最敏感的影像手段,有助于指导挽救治疗。
- 为定位复发部位而行的PSMA PET具有预后价值,病灶数目越多预示挽救放疗或手术干预的结局越差。
- PSMA PET有助于预测晚期远处转移患者对化疗、一线和二线雄激素剥夺治疗及PSMA靶向放射性配体治疗的反应。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein expressed in the majority of prostate cancer (PCa). PSMA has an enzymatic function that makes metabolic substrates such as folate available for utilization by PCa cells. Intracellular folate availability drives aggressive tumor phenotype. PSMA expression is, therefore, a marker of aggressive tumor biology. The large extracellular domain of PSMA is available for targeting by diagnostic and therapeutic radionuclides, making it a suitable cellular epitope for theranostics. PET imaging of radiolabeled PSMA ligands has several prognostic utilities. In the prebiopsy setting, intense PSMA avidity in a prostate lesion correlate well with clinically significant PCa (csPCa) on histology. When used for staging, PSMA PET imaging outperforms conventional imaging for the accurate staging of primary PCa, and findings on imaging predict post-treatment outcomes. The biggest contribution of PSMA PET imaging to PCa management is in the biochemical recurrence setting, where it has emerged as the most sensitive imaging modality for the localization of PCa recurrence by helping to guide salvage therapy. PSMA PET obtained for localizing the site of recurrence is prognostic, such that a higher lesion number predicts a less favorable outcome to salvage radiotherapy or surgical intervention. Systemic therapy is given to patients with advanced PCa with distant metastasis. PSMA PET is useful for predicting response to treatments with chemotherapy, first- and second-line androgen deprivation therapies, and PSMA-targeted radioligand therapy. Artificial intelligence using machine learning algorithms allows for the mining of information from clinical images not visible to the human eyes. Artificial intelligence applied to PSMA PET images, therefore, holds great promise for prognostication in PCa management.
引用
- Lawal IO, Ndlovu H, Kgatle M, et al. Prognostic Value of PSMA PET/CT in Prostate Cancer. Semin Nucl Med. 2023. PMID: 37482489. doi:10.1053/j.semnuclmed.2023.07.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。